BioCentury
ARTICLE | Company News

Acura, KemPharm deal

October 31, 2016 7:00 AM UTC

Acura granted KemPharm rights to develop and commercialize up to three immediate-release candidates using Acura’s version abuse-deterrent technology. KemPharm said it will develop KP415, a prodrug of ...